Authors: LINCOFF AM TCHENG JE CALIFF RM CABOT CF MILLER DP BOOTH JE MONTAGUE EA ANDERSON KM TOPOL EJ

Citation: Am. Lincoff et al., ABCIXIMAB (C7E3 FAB, REOPRO) WITH REDUCED HEPARIN DOSING DURING CORONARY INTERVENTION - FINAL RESULTS OF THE EPILOG TRIAL, Journal of the American College of Cardiology, 29(2), 1997, pp. 7396-7396

Authors: MONTAGUE EA BOOTH JE MILLER DP MALONE KJ ZOVKIC VE CLEMONS PV LINCOFF AM TOPOL EJ

Citation: Ea. Montague et al., IS THERE A NEED FOR INDEPENDENT END-POINT REVIEW FOR ISCHEMIC EVENTS IN CARDIOVASCULAR TRIALS, Circulation, 96(8), 1997, pp. 2825-2825

Authors: WARD SR LINCOFF AM MILLER DP BOOTH JE MONTAGUE EA TCHENG J TOPOL EJ

Citation: Sr. Ward et al., CLINICAL OUTCOME IS IMPROVED AT 30 DAYS REGARDLESS OF PRETREATMENT CLINICAL AND ANGIOGRAPHIC RISK IN PATIENTS RECEIVING ABCIXIMAB FOR ANGIOPLASTY - RESULTS FROM THE EPILOG STUDY, Circulation, 94(8), 1996, pp. 1151-1151

Authors: AGUIRRE FV TALLEY DJ FERGUSON JJ TCHENG J KLEIMAN NS MONTAGUE EA BOOTH JE LINCOFF AM

Citation: Fv. Aguirre et al., EFFICACY OF ABCIXIMAB, DESPITE PATIENT WEIGHT, USING LOWER HEPARIN DOSING DURING PERCUTANEOUS CORONARY INTERVENTIONS, Circulation, 94(8), 1996, pp. 1153-1153

Authors: LINCOFF AM TCHENG JE MILLER DP BOOTH JE MONTAGUE EA TOPOL EJ

Citation: Am. Lincoff et al., MARKED ENHANCEMENT OF CLINICAL EFFICACY OF PLATELET GP IIB IIIA BLOCKADE WITH C7E3 FAB (ABCIXIMAB) LINKED TO REDUCTION IN BLEEDING COMPLICATIONS - OUTCOME IN THE EPILOG AND EPIC TRIALS/, Circulation, 94(8), 1996, pp. 2185-2185

Authors: BROWN KJ EVANS DJ CASEDONTE M MONTAGUE EA WHITMAN G

Citation: Kj. Brown et al., TIMING OF VASOVAGAL REACTIONS ASSOCIATED WITH REMOVAL OF FEMORAL ARTERIAL SHEATHS, Circulation, 88(4), 1993, pp. 196-196